source
- Two biotech firms announce reverse mergers to list experimental bispecific antibody and BTK inhibitor on NasdaqTwo biotech companies have each entered reverse merger agreements to become publicly traded on Nasdaq. One firm, based in China, is developing a bispecific antibody and will use the merger to brin…
- Nanoparticle-loaded chemotherapy crosses blood-brain barrier in mice after glioblastoma surgery, study showsResearchers at the University of Manchester have demonstrated that a standard chemotherapy drug can reach the brain when packaged in liposome nanoparticles and given shortly after tumor removal in…